A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy
Launched by UNIVERSITY OF DUBLIN, TRINITY COLLEGE · Feb 19, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special exercise program designed for cancer patients who are undergoing chemotherapy. The main goal is to see if this program can be successfully offered to patients and how well they can follow it while they are receiving treatment. The program is tailored to the individual needs of each patient, which means it considers their unique situation and how they are feeling during chemotherapy.
To participate in this study, you must be over 18 years old and have a confirmed diagnosis of early to mid-stage breast, ovarian, or colorectal cancer. You should also be scheduled to receive chemotherapy with the goal of curing your cancer and have your doctor's approval to engage in regular exercise. If you have advanced cancer, are receiving certain types of chemotherapy, or have other specific conditions, you may not be able to take part in this trial. If you join, you can expect to work with a team to develop an exercise plan that suits your needs while you go through your treatment. This trial is currently looking for participants, so it’s a great opportunity to explore how exercise might help you during your chemotherapy journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged \>18.
- • Histological confirmed diagnosis of stage I to IIIc breast, ovarian or colorectal cancer.
- • Scheduled to receive chemotherapy ± immunotherapy with curative intent.
- • Medical clearance from oncologist to partake in regular exercise in accordance with American College of Sports Medicine (ACSM) preparticipation screening algorithm.
- • Ability to provide written informed consent.
- Exclusion Criteria:
- • Advanced/metastatic disease.
- • Scheduled to receive concurrent chemoradiotherapy.
- • Scheduled to receive high-dose chemotherapy during hospital admission.
About University Of Dublin, Trinity College
Trinity College Dublin, a prestigious university renowned for its commitment to research excellence and innovation, serves as a leading sponsor of clinical trials. With a strong emphasis on advancing medical knowledge and improving patient outcomes, the university leverages its interdisciplinary expertise and state-of-the-art facilities to conduct high-quality clinical research. Collaborating with healthcare professionals and industry partners, Trinity College aims to translate scientific discoveries into practical applications, fostering an environment of rigorous inquiry and ethical standards in clinical investigation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dublin, , Ireland
Dublin, Leinster, Ireland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported